INDO EURO INDCHEM LTD. (INDOEURO) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of INDO EURO INDCHEM LTD. ₹6.37, price ₹8.10, upside -21.4%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range ₹4.61 – ₹37.90 · fair‑value band ₹4.46 – ₹8.28 · the ₹8.10 price screens above the ₹6.37 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow INDO EURO INDCHEM in your weekly email
Every Wednesday you see whether INDO EURO INDCHEM is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Indo Euro Indchem Limited trades in specialty chemicals, poultry feeds, base and tissue papers, press plates, laminates, and corrugated boxes in India. The company was formerly known as Rinku Polychem Limited. Indo Euro Indchem Limited was incorporated in 1990 and is based in Mumbai, India.
Stock analysis
INDO EURO INDCHEM LTD. (INDOEURO) currently trades at ₹8.10, while our model-based Fair Value estimate is ₹6.37, 21.4% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹14.46 per share, and 13 of the 16 models we run sit above the ₹8.10 price.
Bear case: the Multiples group reads lowest at ₹6.00, and 3 of the 16 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹4.46 (bear) to ₹8.28 (bull), the price of ₹8.10 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
INDO EURO INDCHEM LTD. reported revenue of ₹137M in FY2026 versus ₹226M in FY2022, a compound −11.8%/yr. Reported net income was ₹3.2M in FY2026, compounding −11.1%/yr from FY2022.
Key figures
Market cap ₹73.3M (≈ $762K) · P/E ratio 26.1 · P/S ratio 0.61 · EPS (TTM) ₹0.3100 · Net margin 2.3% · Return on equity 2.8% · Return on assets (EBIT) −0.4% · Operating margin 1.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 53% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −21%, INDOEURO screens cheaper than that median.
Fair Value models
Bear ₹4.46Fair Value ₹6.37Bull ₹8.28
Price ₹8.10 · Upside -21.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.1588 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.73/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−1.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.5%
Start year 2021 (pandemic). Over 10 years: +9.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.8%
’14
’15
’16
’17
’18
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+36.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+36.5%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.36.5% vs 14.6%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → −1%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 694 stocks
Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−21.4% · Above median
Profitability
Return on equity (TTM)2.8% · Below median
Return on assets−0.2% · Bottom 25%
Net margin (TTM)1.7% · Below median
Operating margin (TTM)1.2% · Bottom 25%
Growth and dividend
Revenue growth163.2% · Top 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "INDO EURO INDCHEM LTD. Fair Value". https://www.fairvalue-calculator.com/stock/INDOEURO
Frequently asked questions
Is INDO EURO INDCHEM LTD. (INDOEURO) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of ₹6.37 versus a price of ₹8.10, about −21% upside (overvalued).
What is the fair value of INDOEURO?
Our model-based fair value for INDO EURO INDCHEM LTD. is ₹6.37 (as of Oct 3, 2026), built from audited fundamentals. The current price: ₹8.10.
What is the quality score of INDOEURO?
INDO EURO INDCHEM LTD. has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for INDO EURO INDCHEM LTD. (INDOEURO)?
Our model-based price target is the fair value of ₹6.37 (as of Oct 3, 2026) from 16 valuation models. Cautious scenario ₹4.46, optimistic scenario ₹8.28. It is a calculation from audited fundamentals, not an analyst target.
What is the INDO EURO INDCHEM LTD. stock forecast for 2026?
Our models put fair value at ₹6.37, about −21% upside versus a price of ₹8.10 (overvalued). Cautious scenario ₹4.46, optimistic scenario ₹8.28. The calculation is refreshed regularly with new filings.
What is the revenue of INDO EURO INDCHEM LTD. (INDOEURO)?
INDO EURO INDCHEM LTD. reported trailing-twelve-month revenue of about ₹162M (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of INDO EURO INDCHEM LTD. (INDOEURO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For INDO EURO INDCHEM LTD. it is ₹6.37 per share (as of Oct 3, 2026), against a price of ₹8.10. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is INDO EURO INDCHEM LTD. stock overvalued or undervalued in 2026?
As of Oct 3, 2026, INDOEURO trades above its calculated fair value: price ₹8.10, fair value ₹6.37, a gap of about −21% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INDOEURO?
No. The price is what the market pays today (₹8.10); the fair value is what the company's own numbers justify (₹6.37). For INDO EURO INDCHEM LTD. the two are ₹1.73 per share apart. That gap is exactly why we show both numbers side by side.
How much is INDO EURO INDCHEM LTD. worth?
The market values INDO EURO INDCHEM LTD. at about ₹73.3M (market capitalisation, as of Oct 3, 2026). Per share that is ₹8.10; our models calculate a fair value of ₹6.37 per share.
What do the bullish and bearish scenarios say about INDOEURO?
Our models span a range for INDO EURO INDCHEM LTD.: cautious scenario ₹4.46, base ₹6.37, optimistic ₹8.28 per share (as of Oct 3, 2026, price ₹8.10). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of INDOEURO?
INDO EURO INDCHEM LTD. trades at a price-to-earnings ratio of 26.1 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹6.37 is built from several models across several years. Other multiples: P/B 0.6, P/S 0.5.
How solid is the balance sheet of INDO EURO INDCHEM LTD. (INDOEURO)?
Balance-sheet figures for INDO EURO INDCHEM LTD. (as of Oct 3, 2026): return on equity 2.8%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is INDOEURO from its 52-week high?
INDO EURO INDCHEM LTD. trades at ₹8.10, about 53% below its 52-week high of ₹17.38 and 2% above the low of ₹7.94 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹6.37 is for.
Which stocks are comparable to INDO EURO INDCHEM LTD.?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is INDO EURO INDCHEM LTD. stock attractive at the current price?
The data as of Oct 3, 2026: price ₹8.10, calculated fair value ₹6.37 (−21%), Quality Score 60/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INDOEURO calculated?
We run INDO EURO INDCHEM LTD. through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹6.37, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. INDO EURO INDCHEM LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of INDO EURO INDCHEM LTD. (INDOEURO)?
The closing price on Oct 1, 2026 was ₹8.10. Our model-based fair value is ₹6.37, about −21% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with INDO EURO INDCHEM LTD. right now?
Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹4.46 to ₹8.28) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of INDO EURO INDCHEM LTD.
How large is the market capitalisation of INDO EURO INDCHEM LTD. (INDOEURO)?
The market capitalisation of INDO EURO INDCHEM LTD. is ₹73.3M (≈ $762K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of INDO EURO INDCHEM LTD. (INDOEURO)?
The price-to-sales ratio of INDO EURO INDCHEM LTD. is 0.61 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of INDO EURO INDCHEM LTD. (INDOEURO)?
Earnings per share at INDO EURO INDCHEM LTD. are ₹0.3100 (price ÷ EPS = P/E 26.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of INDO EURO INDCHEM LTD. (INDOEURO)?
The net margin of INDO EURO INDCHEM LTD. is 2.3% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of INDO EURO INDCHEM LTD. (INDOEURO)?
The return on equity (ROE) of INDO EURO INDCHEM LTD. is 2.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of INDO EURO INDCHEM LTD. (INDOEURO)?
On an EBIT basis the return on assets of INDO EURO INDCHEM LTD. is −0.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of INDO EURO INDCHEM LTD. (INDOEURO)?
The operating margin of INDO EURO INDCHEM LTD. is 1.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at INDO EURO INDCHEM LTD. (INDOEURO)?
Revenue at INDO EURO INDCHEM LTD. is growing +163% versus a year earlier (3y avg +10.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at INDO EURO INDCHEM LTD. (INDOEURO)?
Earnings per share at INDO EURO INDCHEM LTD. are growing −25.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does INDO EURO INDCHEM LTD. (INDOEURO) generate?
The free cash flow of INDO EURO INDCHEM LTD. is ₹90.7M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does INDO EURO INDCHEM LTD. (INDOEURO) carry?
The net debt of INDO EURO INDCHEM LTD. is ₹409K (fiscal year 2020, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch INDO EURO INDCHEM LTD. in the live analysis
One click puts INDO EURO INDCHEM LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
